New Delhi: Soon-to-be brides and grooms in India are increasingly turning to weight-loss injections as a quick way to shed kilos before their wedding day.
Wellness clinics are now marketing packages that combine medication with fitness and grooming services.
Wedding weight-loss trend rise in India
New Delhi-based Klarity Skin Clinic has introduced a “Mounjaro bride” package, while other clinics have incorporated injections into pre-wedding makeovers traditionally focused on skincare and hair styling. In a promotional video, Klarity clinic offers “guided nutrition, Mounjaro and smart workouts” for brides preparing for their big day.
Doctors see rising demand
Doctors say inquiries have surged in recent months, with many brides and some grooms seeking prescriptions. “Over the last few months, over 20% of the queries we’ve received for obesity injections are from to-be brides, who also openly give us a timeline on how soon they are getting married,” said Rajat Goel, a bariatric surgeon. He added that prescriptions are only given when medically necessary, not for cosmetic reasons.
Societal pressure drives choices
Weddings in India often come with expectations around appearance, especially in arranged marriages. Aditi, a 26-year-old from Mumbai, told Reuters, “When I see the result, I feel happy. If I am not happy, I don’t feel confident. I did not want to feel that way at the time of the wedding.” She lost 10 kg before her ceremony.
For some, the decision is driven by social stigma. Priya, a 27-year-old from Bengaluru, said, “I’ve had men and their families reject my proposal because of my weight. I was told I was fat.” She lost over 12 kg using weight-loss medication but continues her search for a partner.
Growing market and access
Pharmaceutical giants Eli Lilly and Novo Nordisk launched obesity drugs in India last year, expanding access. The lowest dose of Mounjaro costs around Rs 13,125 per month, while higher doses can go up to Rs 25,781. Wegovy is priced between Rs 5,660 and Rs 16,400 per month. Cheaper versions are also entering the market. It is expected that the market will reach Rs 80 billion by 2030.
Misuse concerns flagged
Health experts warn against using these drugs as quick fixes. “We understand the curiosity, but this cannot be a quick fix,” said Dr Swati Pradhan. She emphasised that such treatments should be reserved for medically eligible individuals and combined with lifestyle changes.
